Electrocardiographic features in a patient with the coexistence of long QT syndrome and coronary vasospasm

PACE - Pacing and Clinical Electrophysiology

Volumn 31, Issue 8, 2008, Pages 1065-1069

  Tanaka, Yasuaki ^a,d   Nishizaki, Mitsuhiro ^a   Yamawake, Noriyoshi ^a   Sakurada, Harumizu ^b   Hiraoka, Masayasu ^c  

^a Yokohama Minami Kyosai Hospital   (Japan)

^b TOKYO METROPOLITAN HIROO HOSPITAL   (Japan)

^c TOKYO MEDICAL AND DENTAL UNIVERSITY   (Japan)

^d NONE

Author keywords

Acetylcholine; Coronary vasospasm; Epinephrine; Glucose; ICD; Insulin; Ion channel; Long QT; Sudden cardiac death; Vasospastic angina; VF

Indexed keywords

ADULT; ARTICLE; CASE REPORT; CLINICAL FEATURE; ELECTROCARDIOGRAM; FAMILY HISTORY; FEMALE; HEART ARREST; HEART VENTRICLE FIBRILLATION; HUMAN; ORAL GLUCOSE TOLERANCE TEST; QT PROLONGATION; RESUSCITATION; SINUS RHYTHM; TREADMILL EXERCISE; VASOSPASM;

ACETYLCHOLINE; ADOLESCENT; CORONARY VASOSPASM; DIAGNOSIS, DIFFERENTIAL; ELECTROCARDIOGRAPHY; FEMALE; HUMANS; LONG QT SYNDROME;

EID: 48249132459     PISSN: 01478389     EISSN: 15408159     Source Type: Journal    
DOI: 10.1111/j.1540-8159.2008.01137.x     Document Type: Article

References (20)

1. Moss AJ, Schwartz PJ, Crampton RS, Locati E, Carleen E. The long QT syndrome: A prospective international study. Circulation 1985 71 : 17 21.
2. Wang Q, Shen J, Splawski I, Atkinson D, Li Z, Robinson JL, Moss AJ, et al. SCN5A mutations associated with an inherited cardiac arrhythmia, long QT syndrome. Cell 1995 80 : 805 811.
3. Curran ME, Splawski I, Timothy KW, Vincent GM, Green ED, Keating MT. A molecular basis for cardiac arrhythmia: HERG mutations cause long QT syndrome. Cell 1995 80 : 795 803.
4. Zareba W, Moss AJ, Schwartz PJ, Vincent GM, Robinson JL, Priori SG, Benhorin J, et al. Influence of genotype on the clinical course of the long-QT syndrome: International long-QT Syndrome Registry Research Group. N Engl J Med 1998 339 : 960 965.
5. Schwrtz PJ, Priori SG, Spazzolini C, Moss AJ, Vincent GM, Napolitano C, Denjoy I, et al. Genotype-phenotype correlation in the long-QT syndrome: Gene specific triggers for life-threatening arrhythmias. Circulation 2001 103 : 89 95.
6. Splawski I, Timothy KW, Sharpe LM, Decher N, Kumar P, Bloise R, Napolitano C, et al. Ca(V)1.2 calcium channel dysfunction causes a multisystem disorder including arrhythmia and autism. Cell 2004 119 : 19 31.
7. Tester DJ, Will ML, Haglund CM, Ackerman MJ. Compendium of cardiac channel mutations in 541 consecutive unrelated patients referred for long QT syndrome genetic testing. Heart Rhythm 2005 2 : 507 517.
8. Noda T, Takagi H, Kurita T, Suyama K, Nagaya N, Taguchi A, Aihara N, et al. Gene-specific response of dynamic ventricular repolarization to sympathetic stimulation in LQT1, LQT2 and LQT3 forms of congenital long QT syndrome. Eur Heart J 2002 23 : 975 983.
9. Shimizu W, Noda T, Takaki H, Nagaya N, Satomi K, Kurita T, Suyama K, et al. Diagnostic value of epinephrine test for genotyping LQT1, LQT2, and LQT3 forms of congenital long QT syndrome. Heart Rhythm 2004 1 : 276 283.
10. Nishizaki M, Ashikaga T, Yamawake N, Fujii H, Arita M, Sumitomo N, Sakurada H, et al. Effect of glucose-induced insulin secretion on ventricular repolarization in patients with congenital long QT syndrome. Circulation Journal 2002 66 : 35 40.
11. Aizawa Y, Washizuka T, Igarashi Y, Kitazawa H, Chinushi M, Abe A, Shibata A. Acetylcholine-induced prolongation of the QT interval in idiopathic long QT syndrome. Am J Cardiol 1996 77 : 879 882.
12. Furushima H, Niwano S, Chinushi M, Yamaura M, Taneda K, Washizuka T, Aizawa Y. Effect of atropine on QT prolongation and Torsade de Pointes induced by intracoronary acetylcholine in the long QT syndrome. Am J Cardiol 1999 83 : 714 718.
13. Shimizu W, Antzelevitch C. Sodium channel block with mexiletine is effective in reducing dispersion of repolarization and preventing torsade des pointes in LQT2 and LQT3 models of the long-QT syndrome. Circulation 1997 96 : 2038 2047.
14. Huckell VF, Mclaughlin PR, Morch JE, Wigle ED, Adelman AG. Prinzmetal's angina with documented coronary artery spasm. Treatment and follow-up. Br Heart J 1981 45 : 649 655.
15. Vatta M, Ackerman MJ, Ye B, Makielski JC, Ughanze EE, Taylor EW, Tester DJ, et al. Mutation caveolin-3 induces persistent late sodium current and is associated with long-QT syndrome. Circulation 2006 114 : 2104 2112.
16. Moss AJ, Zareba W, Benhorin J, Locati EH, Hall WJ, Robinson JL, Schwartz PJ, et al. ECG T-wave patterns in genetically distinct forms of the hereditary long QT syndrome. Circulation 1995 92 : 2929 2934.
17. 2+ current in rat cardiac myocytes. Cardiovas Res 1998 42 : 113 120.
18. Yoshimura M, Yasue H, Nakayama M, Shimasaki Y, Sumida H, Sugiyama S, Kugiyama K, et al. A missense Glu298Asp variant in the endothelial nitric oxide synthase gene is associated with coronary spasm in the Japanese. Hum Genet 1998 103 : 65 69.
19. Moss AJ, Zareba W, Hall WJ, Schwartz PJ, Crampton RS, Benforin J, Vincent GM, et al. Effectiveness and limitations of beta-blocker therapy in congenital long-QT syndrome. Circulation 2000 101 : 616 623.
20. Zareba W, Moss AJ, Daubert JP, Hall WJ, Robinson JL, Andrews M. Implantable cardioverter defibrillator in high-risk long QT syndrome patients. J Cardiovasc Electrophysiol 2003 14 : 337 341.